tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYTO Stock Latest News

Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
Press ReleasesAltamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
10h ago
CYTO
Altamira Issues Pre-Funded Share Purchase Warrant
PremiumCompany Announcements
Altamira Issues Pre-Funded Share Purchase Warrant
1d ago
6K
CYTO
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
PremiumPress Releases
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
1d ago
CYTO
Altamira Therapeutics announces pricing of $12M offering
PremiumThe Fly
Altamira Therapeutics announces pricing of $12M offering
2d ago
CYTO
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
PremiumPress Releases
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
3d ago
CYTO
Altamira announces expansion of Bentrio license, distribution agreement
PremiumThe FlyAltamira announces expansion of Bentrio license, distribution agreement
4d ago
CYTO
Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia
Premium
Press Releases
Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia
4d ago
CYTO
Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11
Premium
Press Releases
Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11
17d ago
CYTO
Altamira Therapeutics announces extension of Bentrio distribution agreement
PremiumThe Fly
Altamira Therapeutics announces extension of Bentrio distribution agreement
28d ago
CYTO
Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark
PremiumPress Releases
Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark
28d ago
CYTO
Altamira Therapeutics files to sell common stock, warrants, no amount given
PremiumThe Fly
Altamira Therapeutics files to sell common stock, warrants, no amount given
29d ago
CYTO
Altamira Therapeutics announces confirmed suitability of Bentrio for athletes
PremiumThe Fly
Altamira Therapeutics announces confirmed suitability of Bentrio for athletes
1M ago
CYTO
Altamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited Substances
PremiumPress ReleasesAltamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited Substances
1M ago
CYTO
Altamira Therapeutics announces publication of article on Zbtb46 mRNA
Premium
The Fly
Altamira Therapeutics announces publication of article on Zbtb46 mRNA
1M ago
CYTO
Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models
Premium
Press Releases
Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models
1M ago
CYTO
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
PremiumPress Releases
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
2M ago
CYTO
Altamira Therapeutics announces publication of preclinical data on SOD2 mRNA
PremiumThe Fly
Altamira Therapeutics announces publication of preclinical data on SOD2 mRNA
2M ago
CYTO
Altamira Therapeutics announces publication on betahistine
PremiumThe Fly
Altamira Therapeutics announces publication on betahistine
3M ago
CYTO
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
PremiumPress Releases
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
3M ago
CYTO
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
PremiumPress ReleasesAltamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
4M ago
CYTO
Altamira Therapeutics announces publication of results from NASAR trial
Premium
The Fly
Altamira Therapeutics announces publication of results from NASAR trial
4M ago
CYTO
Altamira Shareholders Approve Key Corporate Changes
Premium
Company Announcements
Altamira Shareholders Approve Key Corporate Changes
4M ago
6K
CYTO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >